Professional Documents
Culture Documents
Hyperbilirubinemia
Pathophysiology
Adults appear jaundiced when the serum bilirubin level is >2 mg/dL
Transport
Uptake
Conjugation
Excretion
Sulfonamides
Moxalactam
Fusidic acid
Radiographic contrast media for cholangiography (sodium iodipamide, sodium ipodate, iopanoic
acid, meglumine loglycamate)
Aspirin
Apazone
Tolbutamide
PHYSIOLOGIC HYPERBILIRUBINEMIA
The serum UCB level of most newborn infants rises to >2 mg/dL in the first week of life.
This level usually rises in full-term infants to a peak of 6 to 8 mg/dL by 3 days of age
and then falls.
In premature infants, the peak may be 10 to 12 mg/dL on the fifth day of life,
possibly rising >15 mg/dL without any specific abnormality of bilirubin metabolism.
Levels <2 mg/dL may not be seen until 1 month of age in both full-term and
premature infants
PHYSIOLOGIC HYPERBILIRUBINEMIA
1. Increased RBC volume per kilogram and decreased RBC survival (90 day versus 120 day) in
infants compared with adults.
C. Defective uptake of bilirubin from plasma caused by decreased ligandin and binding of
ligandin by other anions.
NONPHYSIOLOGIC HYPERBILIRUBINEMIA
1. Onset of jaundice before 24 hours of age.
2. Any elevation of serum bilirubin that requires phototherapy (see Figs.
18.2, 18.3, 18.4 and VI.D).
3. A rise in serum bilirubin levels of >0.5 mg/dL/hour.
4. Signs of underlying illness in any infant (vomiting, lethargy, poor
feeding, excessive weight loss, apnea, tachypnea, or temperature
instability).
5. Jaundice persisting after 8 days in a term infant or after 14 days in a
premature infant.
Indirect causes